Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov enrollment closed early-phase tilt small index

Gestational Trophoblastic Tumor: early-phase trial registry

A small indexed set (5 trials) with no open enrollment listed right now.

Corpus placement: #3,391 of 28,707 conditions by registered trial count.

Browse conditions → How counts are built

5 US clinical trials · none currently recruiting · #3,391 of 28,707 conditions by registered trial count

Gestational Trophoblastic Tumor: 5 US clinical trials tracked, none currently recruiting.

Gestational Trophoblastic Tumor is the subject of 5 registered US clinical trials on ClinicalTrials.gov, none currently recruiting. 0 are in Phase 3-4 (later-stage) and 4 in Phase 1-2 (earlier-stage). The most active sponsor is Indiana University School of Medicine, running 1 of these trials.

Enrollment posture brief

Registry condition gestational-trophoblastic-tumor

OPEN 0 | RECR 0% | LATE 0 | EARLY 4 | RANK #3391 | SPON 1

Volume-matched condition peers

Nearest open-share peer: Accelerated Phase Chronic Myelogenous Leukemia (0% recruiting · 12 trials)

Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%Gestational Trophoblasti (th…0%
Open-enrollment share among volume-matched conditions near Gestational Trophoblastic Tumor

Gestational Trophoblastic Tumor has no open enrollment in this registry pull (5 archived studies). Peers show how other volume-matched labels compare on open share. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Gestational Trophoblastic Tumor on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Gestational Trophoblastic Tumor is recruiting below its size-band peers.

    0 of 5 indexed trials (0%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Gestational Trophoblastic Tumor research.

    Indiana University School of Medicine accounts for 1 of 5 trials (20%). 5 distinct sponsors appear on at least one study for this condition label.

  3. Gestational Trophoblastic Tumor research is mostly interventional.

    5 interventional and 0 observational studies make up this index (100% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 12Phase 22

Phase Distribution

PhaseTrial count
Phase 1 2
Phase 2 2

Top Sponsors

Indiana University School of Medicine 1 trials
Fred Hutchinson Cancer Center 1 trials
Case Comprehensive Cancer Center 1 trials
National Institutes of Health Clinical Center (CC) 1 trials
University of Wisconsin, Madison 1 trials

Named interventions

Most-linked intervention names on Gestational Trophoblastic Tumor records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

alemtuzumab Biological
2 trials
methylprednisolone Drug
2 trials
ravuconazole Drug
1 trials
immunologic technique Other
1 trials
recombinant interleukin-12 Biological
1 trials
informational intervention Other
1 trials
flow cytometry Other
1 trials
counseling intervention Other
1 trials

US sites by state

Facility locations filed on Gestational Trophoblastic Tumor trials. A trial with sites in several states counts in each.

Wisconsin 1 trials
Washington 1 trials
Texas 1 trials
Pennsylvania 1 trials
Oregon 1 trials
Ohio 1 trials
New York 1 trials
Maryland 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Gestational Trophoblastic Tumor page

5 registered trials, 0 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • No Gestational Trophoblastic Tumor trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
  • Indiana University School of Medicine sponsors the most Gestational Trophoblastic Tumor trials on record, review their full trial history before evaluating a specific study. See Indiana University School of Medicine's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Gestational Trophoblastic Tumor condition card totals 5 registered trials; most-linked intervention alemtuzumab; top US site state Wisconsin. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.